Riboflavin

Riboflavin has been studied in 89 papers since 2016: 1 trial and 66 observational studies in people, 6 in animals, 7 in cells, 9 reviews; 22 in the past year. The newest story, Nov 16, 2026: “Chemical mixture linked to faster biological aging in adults”.

Intervention

89 papers study it57 more mention it43 findingsUpdated

PubChemChEBIMeSH

6 new papers in 30 daysSee all 146 papers on riboflavin

At a glance

A fly study reports lifespan extension with riboflavin, but lifespan shortens at 10 and 100 mg/mL. Independent labs link human dietary intake with less cognitive impairment; another study links it with higher cognitive dysfunction risk. Most registered trials—none classified as aging trials—ended over a year ago without posted results. Some authors have company affiliations, and some trials have company sponsors.

43 findings in 35 papers from 2016 to 2026, 6 of them since May 2026

Independent labs found the same change in worms or flies and people. 30 independent labs in 10 countries; 33 trials, none about aging, 21 with no results posted.

“Higher intakes of antioxidant vitamins, riboflavin, and folate were associated with 20% and 19% reduced intact AAA incidence, respectively.”
Oxidative stress-related genetic variation and antioxidant vitamin intake in intact and ruptured abdominal aortic aneurysm: a Swedish population-based retrospective cohort studyEuropean journal of preventive cardiology2023doi:10.1093/eurjpc/zwad271

5 of its findings point the other way.

Worms or flies and humans: replicated by independent labs. Cells and mice: a single group.
  • 30 independent labs in 10 countries
  • 5 findings against
  • 33 trials, none about aging, 21 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 2 of 46 findings with company ties
  • 5 of 33 trials sponsored by its developers
  • Human trial1
  • Humans66
  • Animals2
  • Model organisms4
  • Cells7

What did lifespan studies of riboflavin find?

DrugAge

DrugAge records 4 results from 1 paper: 4 in D. melanogaster. Average lifespan is the mean or the median, as each paper reports it.

What did studies of riboflavin find?

16

Studies of riboflavin measured 16 outcomes, among them cellular senescence, blood pressure and gastric cancer.

Cellular senescence

upin cells1downin human cells1

2 studies
  1. Riboflavin decreases cellular senescence in human cells (dependent on SLC52A1 riboflavin transport activity).

    Cellsdependent on SLC52A1 riboflavin transport activity

  2. Riboflavin increases cellular senescence in cells with DAO expression.

    Cellswith DAO expression

More on Cellular senescence

Blood pressure

downin humans1

1 study
  1. Riboflavin decreases blood pressure in humans (MTHFR 677TT genotype; independently of antihypertensive medications).

    ReviewMTHFR 677TT genotype; independently of antihypertensive medications

Gastric cancer

no changein humans1OR 0.97

1 study
  1. Riboflavin was not clearly linked with gastric cancer in humans (per one-quartile increase in intake) (OR=0.97 (95% CI = 0.93-1.02)).

    Humansper one-quartile increase in intake

More on Gastric cancer

RTBDN subcellular localization

upin mice1

1 study
  1. Riboflavin improves RTBDN subcellular localization in mice (riboflavin repletion after fasting).

    Animalsriboflavin repletion after fastingretina

    Eye protein shifts location with nutrients and light in mice

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Syncytialization

upin human cells1

1 study
  1. Riboflavin improves syncytialization in DHODH-inhibited human trophoblast stem cells.

    Cellsin DHODH-inhibited human trophoblast stem cells

Bone mineral density

upin humans1

1 study
  1. Riboflavin is linked with higher bone mineral density in humans (β = 0.020 (95% CI: 0.007-0.033)).

    Humansfemurfemales

LSD1 demethylation activity

upin cells1

1 study
  1. Riboflavin increases LSD1 demethylation activity in cells (senescence-inducing stress; riboflavin uptake-dependent).

    Cellssenescence-inducing stress; riboflavin uptake-dependent

Mortality

no changein humans1

1 study
  1. Riboflavin was not clearly linked with mortality in participants without dry mouth.

    Humansin participants without dry mouth

Climbing ability

upin flies1

1 study
  1. Riboflavin improves climbing ability in flies (Appld mutants).

    Model organismsAppld mutants

Mitochondrial membrane potential

upin human cells1

1 study
  1. Riboflavin increases mitochondrial membrane potential in human cells (mediated by mitochondrial electron transport chain complex II).

    Cellsmediated by mitochondrial electron transport chain complex II

More on Mitochondrial membrane potential

All 16

What is riboflavin linked with?

22

Studies link riboflavin with 22 measures, most often cognitive function (3 studies), cognitive impairment (2) and hypertension (2).

Cognitive function

upin humans2downin humans1OR 0.72–0.74

3 studies
  1. Riboflavin is linked with a lower risk of cognitive function in humans (elevated dietary intake) (OR = 0.74, 95% CI: 0.58-0.95).

    Humanselevated dietary intake

  2. Riboflavin is associated with cognitive function in humans (OR 0.72, 95% CI 0.59-0.88).

    Humansn = 2,893

  3. Riboflavin is associated with cognitive function in humans.

    Humans

Cognitive impairment

downin humans2OR 0.82

2 studies
  1. Riboflavin is associated with cognitive impairment in humans across ensemble machine learning models.

    Humansacross ensemble machine learning models

  2. Riboflavin is linked with a lower risk of cognitive impairment in humans (highest vs lowest quartile of dietary intake, mutually adjusted for other B vitamins) (OR 0.82 (0.69, 0.97), highest vs lowest quartile).

    Humanshighest vs lowest quartile of dietary intake, mutually adjusted for other B vitaminsdietary intakeaverage 20 years follow-up

More on Cognitive impairment

Hypertension

downin humans2OR 0.51–0.607

2 studies
  1. Riboflavin is associated with hypertension in humans (multivariable model) (OR 0.607 [95%CI, 0.507-0.727]).

    Humansmultivariable model

  2. Riboflavin is linked with a lower risk of hypertension in humans (highest vs lowest quartile of dietary intake) (OR 0.51 (95% CI 0.32–0.81), Q4 vs Q1).

    Humanshighest vs lowest quartile of dietary intakedietary intake

More on Hypertension

KDM biological age acceleration

downin humans1

1 study
  1. Riboflavin is associated with KDM biological age acceleration in humans (Attenuation of positive associations with PFHxS and the mixture of six key EDCs).

    HumansAttenuation of positive associations with PFHxS and the mixture of six key EDCshigher intake

    Chemical mixture linked to faster biological aging in adults

    Environment international

More on KDM biological age acceleration

Breast cancer

downin humans1OR 0.93

1 study
  1. Riboflavin is linked with a lower risk of breast cancer in humans (OR 0.93, 95% CI: 0.87, 0.99).

    Humansfemales

More on Breast cancer

TET2-CHIP

upin humans1OR 2.07

1 study
  1. Riboflavin is linked with a higher risk of TET2-CHIP in humans (OR 2.07, 95% CI 1.17-3.69).

    Humansn = 888

More on TET2-CHIP

Chronic kidney disease

downin humans1OR 0.812

1 study
  1. Riboflavin is associated with chronic kidney disease in humans (fully adjusted analysis) (Adjusted OR 0.812 per 1 mg/d increment, 95% CI 0.686–0.962).

    Humansfully adjusted analysiseach 1 mg/d increment

More on Chronic kidney disease

Cognitive dysfunction

upin humans1

1 study
  1. Riboflavin is linked with a higher risk of cognitive dysfunction in humans (ORadj 1.73; 95% CI: 1.44-2.09).

    Humans

Osteoporosis

downin humans1OR 0.613

1 study
  1. Riboflavin is linked with a lower risk of osteoporosis in humans (OR 0.613 (95% CI: 0.454-0.829)).

    Humansfemales

More on Osteoporosis

Sarcopenia

downin humans1

1 study
  1. Riboflavin is linked with a lower risk of sarcopenia in humans (P < 0.05).

    Humans

More on Sarcopenia

All 22

Has riboflavin been tested in people?

0 of 33 about aging

Yes: 1 trial and 66 observational studies in people have been published, and 33 trials are registered.

In trials

All 31

Trial sponsors

Funding

2 grants since 2017

National Institute on Aging$677KGouvernement du Canada | Canadian Institutes of Health ResearchCA$305K

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 7Feb 2026: 6Mar 2026: 1Apr 2026: 0May 2026: 2Jun 2026: 0Jul 2026: 2Aug 2026: 2Sep 2026: 4Oct 2026: 4Nov 2026: 332 papers in 12 months
Environment International

Chemical mixture linked to faster biological aging in adults

In 6,553 adults, combined exposure to six chemicals was linked to biological age acceleration, with an odds ratio of 1.58.In 6,553 adults, combined exposure to six chemicals was linked to biological age acceleration, with an odds ratio of 1.58.

Cross-sectional · 6,553 peoplePopulations
FASEB Journal

Eye protein shifts location with nutrients and light in mice

Experiments in male and female mice found that 16 hours of fasting shifted a vitamin-binding protein toward cone cells without changing its total amount.Experiments in male and female mice found that 16 hours of fasting shifted a vitamin-binding protein toward cone cells without changing its total amount.

Mouse studyEye

See all 146 papers on riboflavin